Palomo HRA, Farca BA, Angulo MD, Ramírez EP

Language: Spanish
References: 10
Page: 229-232
PDF size: 279.08 Kb.

ABSTRACT

With the technological advances in minimally invasive treatments that have emerged in recent years, the therapeutic gastrointestinal endoscopy has combined resection and ablation techniques in order to obtain excellent results in the treatment of precancerous lesions of the gastrointestinal tract. We report the case of a patient with a diagnosis of Barrett’s esophagus with high-grade dysplasia who received endoscopic radiofrequency ablation treatment; he presented complete remission of the intestinal metaplasia. It has been found that radiofrequency ablation is a safe and effective treatment for Barrett’s esophagus with high-grade dysplasia. It reduces the incidence of progression to esophageal adenocarcinoma.

REFERENCES

1. Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013; 11 (10): 1245-1255.

2. Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010; 42 (10): 781-789.

3. Haidry RJ, Lipman G, Banks MR, Butt MA, Sehgal V, Graham D et al. Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma : a prospective multicenter UK registry. Endoscopy. 2015; 47 (11): 980-974.

4. Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BL et al. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut. 2016; 65 (4): 555-562.

5. Chadwick G, Groene O, Markar SR, Hoare J, Cromwell D, Hanna GB. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett’s esophagus: a critical assessment of histologic outcomes and adverse events. Gastrointest Endosc. 2014; 79 (5): 718-731.

6. Dulai PS, Pohl H, Levenick JM, Gordon SR, Mackenzie TA, Rothstein RI. Radiofrequency ablation for long- and ultralong-segment Barrett’s esophagus: a comparative long-term follow-up study. Gastrointest Endosc. 2013; 77 (4): 534-541.

7. Fernández-Esparrach G, Rodríguez-D’Jesús A. Radiofrequency in the treatment of Barrett’s esophagus. Gastroenterol Hepatol. 2011; 34 (1): 35-40.

8. Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR et al. Incidence of esophageal adenocarcinoma and causes of mortality after radiofrequency ablation of Barrett’s esophagus. Gastroenterology. 2015; 149 (7): 1752-1761.

9. Krishnamoorthi R, Singh S, Ragunathan K, A Katzka D, K Wang K, G Iyer P. Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy. Gastrointest Endosc. 2016; 83 (6): 1090-1106.e3.

10. Cotton CC, Wolf WA, Pasricha S, Li N, Madanick RD, Spacek MB et al. Recurrent intestinal metaplasia after radiofrequency ablation for Barrett’s esophagus: endoscopic findings and anatomic location. Gastrointest Endosc. 2015; 81 (6): 1362-1369.